Skip to main content

Table 1 Patients excluded from MRgFUS treatment due to the possibility of underlying malignancy.

From: MRI pelvis screening to guide treatment of pelvic pathology

Reason for Suspected Malignancy Number of Patients
Heterogeneous enhancement with ill-defined areas of hypo-enhancement 3
Overcall 3
Intra-cavitary mass w/blood products and heterogeneous enhancement 2
Intra-cavitary masswith homogenous enhancement 2
Ill-defined borders 1
Heterogeneous enhancement with well-defined hypo-enhancement 1